NeoGenomics, Inc. (NEO) Upgraded to Buy at BTIG

Market Context

NeoGenomics, Inc. operates in the Healthcare sector. The stock currently trades at $19.13 with a market capitalization of $300.9M.

Analyst upgrades often act as catalysts for near-term price movement, particularly when they come from major firms with significant institutional following. BTIG's upgrade suggests their analysts see improving fundamentals, a more favorable risk-reward profile, or upcoming catalysts that could drive the stock higher.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for NeoGenomics, Inc.

Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Oct 06, 2026	BTIG	Buy	N/A
Jul 29, 2026	Needham	Buy	N/A
Jul 24, 2026	Benchmark	Buy	N/A
Apr 29, 2026	TD Cowen	Buy	N/A
Apr 29, 2026	Benchmark	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View NEO Stock Page